Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197743 · ClinicalTrials.gov registry record · Phase 3
Trial of Vitamins in HIV Progression and Transmission
A Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,085
- Enrollment target
NCT00197743 is a Phase 3 study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 1,085 participants.
The verdict
NCT00197743, a Phase 3 study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,085 participants
- Enrollment target
Study Summary
This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant women in Tanzania would slow disease progression and enhance their overall health.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Multivitamins
- DIETARY_SUPPLEMENT Vitamin A + Beta Carotene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,085 participants |
| Start Date | 1995-04 |
| Est. Completion | 2003-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00197743
The ClinicalTrials.gov registry entry for NCT00197743 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,085 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00197743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00197743 about?
NCT00197743 is a clinical study titled "Trial of Vitamins in HIV Progression and Transmission". This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant women in Tanzania would slow disease progression and enhance their overall health.
What is the current status of trial NCT00197743?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,085 participants. The study started on 1995-04. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00197743?
The interventions under investigation include: Placebo (OTHER), Multivitamins (DIETARY_SUPPLEMENT), Vitamin A + Beta Carotene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197743?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.